Venus Concept (VERO) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Q3 2024 revenue was $15.0 million, down 15% year-over-year, with U.S. revenue declining 23% and international revenue flat; net loss attributable to stockholders was $9.3 million, compared to $9.1 million in Q3 2023.
Strategic shift prioritized cash system sales, with 76% of U.S. system sales being cash-based in Q3, up from 69% last year, and a reduction in internal lease program sales.
International distributor sales rose nearly 60%, driven by new and existing partners in APAC and EMEA, with new product registrations in Australia and India expected to benefit future results.
Cash used in operations for the first nine months of 2024 was $7.3 million, a 40% year-over-year reduction, reflecting improved cash management.
The company continues to experience recurring net operating losses and negative cash flows, with an accumulated deficit of $300.9 million as of September 30, 2024.
Financial highlights
Gross profit for Q3 2024 was $9.9 million (66.1% margin), down from $12.2 million (69.2%) in Q3 2023.
Operating expenses for Q3 2024 were $17.1 million, down 10% year-over-year, with reductions in G&A, selling, and R&D expenses.
Operating loss was $7.2 million, net loss was $9.3 million ($1.28/share), and adjusted EBITDA loss was $5.9 million.
Cash and cash equivalents at quarter-end were $4.5 million; total debt was $34.6 million, down from $74.9 million at 2023 year-end.
Cash used in operations for the first nine months was $7.3 million, down 40% year-over-year.
Outlook and guidance
Q4 2024 revenue is expected to be at least $17.0 million, a 6% year-over-year decline but a 13% sequential increase.
Sustained cash flow break-even targeted for the back half of 2025, with Q4 typically a strong cash flow quarter.
Management expects continued macroeconomic headwinds, including high interest rates and tight credit markets, to impact capital equipment sales and customer financing.
Latest events from Venus Concept
- Revenue down 17% year-over-year, but debt reduced and margin improved amid ongoing risks.VERO
Q2 20241 Feb 2026 - Revenue fell 13% in Q4 and 15% for FY24; debt cut by 47% and Q1 2025 revenue to exceed $14M.VERO
Q4 202424 Dec 2025 - Shelf registration enables up to $30.4M in securities sales for global medical technology expansion.VERO
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and key share issuance proposals.VERO
Proxy Filing1 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and major share issuances.VERO
Proxy Filing1 Dec 2025 - Vote sought on a reverse stock split to maintain Nasdaq listing and avoid delisting risk.VERO
Proxy Filing1 Dec 2025 - Vote sought to authorize a reverse stock split to maintain Nasdaq listing and enhance share value.VERO
Proxy Filing1 Dec 2025 - Approval sought for share issuance tied to convertible notes after major debt restructuring.VERO
Proxy Filing1 Dec 2025 - Amended registration statement for a public offering, with auditor consent and executive sign-off.VERO
Registration Filing29 Nov 2025